Slow formation of a pseudoknot structure is rate limiting in the productive co-transcriptional folding of the self-splicing Candida intron

被引:14
|
作者
Zhang, Libin [1 ,2 ]
Bao, Penghui [1 ,2 ]
Leibowitz, Michael J. [3 ,4 ]
Zhang, Yi [1 ,2 ]
机构
[1] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China
[2] Wuhan Univ, Dept Biochem & Mol Biol, Wuhan 430072, Hubei, Peoples R China
[3] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Mol Genet Microbiol & Immunol, Piscataway, NJ 08854 USA
[4] Canc Inst New Jersey, New Brunswick, NJ 08903 USA
基金
中国国家自然科学基金;
关键词
antisense oligonucleotide (AON); Candida albicans; pseudoknot; ribozyme; GROUP-I INTRON; DELTA-VIRUS RIBOZYME; RNA PSEUDOKNOT; TERTIARY INTERACTIONS; TETRAHYMENA-RIBOZYME; SECONDARY STRUCTURES; CRYSTAL-STRUCTURE; ACTIVE STRUCTURE;
D O I
10.1261/rna.1638609
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Pseudoknots play critical roles in packing the active structure of various functional RNAs. The importance of the P3-P7 pseudoknot in refolding of group I intron ribozymes has been recently appreciated, while little is known about the pseudoknot function in co-transcriptional folding. Here we used the Candida group I intron as a model to address the question. We show that co-transcriptional folding of the active self-splicing intron is twice as fast as refolding. The P3-P7 pseudoknot folds slowly during co-transcriptional folding at a rate constant similar to the folding of the active ribozyme, and folding of both P3-P7 and P1-P10 pseudoknots are inhibited by antisense oligonucleotides. We conclude that when RNA folding is coupled with transcription, formation of pseudoknot structures dominates the productive folding pathway and serves as a rate-limiting step in producing the self-splicing competent Candida intron.
引用
收藏
页码:1986 / 1992
页数:7
相关论文
共 1 条
  • [1] Antisense oligonucleotides effectively inhibit the co-transcriptional splicing of a Candida group I intron in vitro and in vivo: Implications for antifungal therapeutics
    Zhang, Libin
    Leibowitz, Michael J.
    Zhang, Yi
    FEBS LETTERS, 2009, 583 (04) : 734 - 738